Personalis Inc.

Personalis, Inc. delivers high‑precision liquid biopsy tests (NeXT Personal, NeXT Dx) and whole‑exome sequencing services for oncology pharma, diagnostics, and clinical research, driving personalized cancer therapy and trial enrollment worldwide.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Professional Services
Industry: Research Services

Employees: 228
HQ: Fremont

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
PSNL	Personalis Inc. Cap: 0.7B	EQUITY	NMS	USD	US71535D1063	Active	📈